Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Merck Sharp & Dohme Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (146)
Australian public assessment report (AusPar) (4)

Date

2018 (1)
2017 (13)
2016 (38)
2015 (87)
2014 (11)

Search

Sponsor content

150 result(s) found, displaying 121 to 130

EMEND (APREPITANT) 125 mg and 80 mg capsule blister tri-pack export only Cancelled under s30(1)(c) of the Act

5 June 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
STOCRIN efavirenz 600mg film coated tablet - bulk Cancelled under s30(1)(c) of the Act

5 June 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
H-B-VAX II HEPATITIS B VACCINE RECOMBINANT hepatitis B - surface antigen recombinant 40mcg/1mL injection vial (thiormersal free) - Export only Cancelled under s30(1)(c) of the Act

5 June 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
STOCRIN (efavirenz) 50mg tablet bottle (export) Cancelled under s30(1)(c) of the Act

5 June 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
STOCRIN (efavirenz) 200mg tablet bottle (export) Cancelled under s30(1)(c) of the Act

5 June 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
GARDASIL Quadrivalent Human Papillomavirus (types 6,11,16,18) Recombinant Vaccine, 20-40-40-20 mcg/0.5mL vial sterile liquid - export only Cancelled under s30(1)(c) of the Act

5 June 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
PROPECIA finasteride 1mg unwaxed tablet bulk - export Cancelled under s30(1)(c) of the Act

5 June 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
Moduretic Tablet 5mg/50mg export only Cancelled under s30(1)(c) of the Act

5 June 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
EMEND IV fosasprepitant 115mg powder for injection vial - export only Cancelled under s30(1)(c) of the Act

5 June 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
GARDASIL Quadrivalent Human Papillomavirus (types 6,11,16,18) Recombinant Vaccine, 20-40-40-20 mcg/0.5mL sterile liquid syringe- export only Cancelled under s30(1)(c) of the Act

5 June 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd

Pages

First page
Previous page
…
Page 7
Page 8
Page 9
Page 10
Page 11
Page 12
Current page 13
Page 14
Page 15
Next page
Last page

Is there anything wrong with this page?

Help us improve

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.